Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants

Completed · Phase 3 · Has a placebo group

Conditions studied: Prematurity, Respiratory Distress Syndrome,Hypoxemia

In brief

Our previous data demonstrated that premature infants treated with inhaled nitric oxide at birth had improved neurodevelopmental outcomes at two years corrected age. We now wish to determine whether this benefit continues through school age.

Key facts

Study ID

NCT00152542

Run by

University of Chicago

People needed

160

Starts

2005-05-01

Expected to finish

2006-09-01

Last updated by the study team

2013-06-12

Who can join

Age: 4 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children who participated in NOVA study and are of school age

You may not qualify if…

• Children who participated in NOVA study but deceased post discharge

Where it is running

• The University of Chicago, Comer Children's Hospital, — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.